A Quick ASCO Update
Research - Initial data from the upcoming ASCO annual meeting (American Society of Clinical Oncology annual meeting) dropped last night when abstracts were released at 5:00 PM … Continue Reading
Read nowAuthor Archives: Editorial Staff
Stocks had a Fine Finish to a Rough Week
Recap - After a mostly red week, stocks gapped higher Friday morning with the latest jobs report. The jobless rate fell to 5.4%, the lowest since 2008, and a … Continue Reading
Read now
A Review of Our Latest Biotech Investing Ideas
Research - Even with Alexion Pharmaceuticals (ALXN) announcing Wednesday morning the acquisition of Synageva (GEVA) for a heady $8 billion, aggressive dip-buyers are still absent in the … Continue Reading
Premium
One Cool Datapoint for Battered Healthcare Investors
Recap - The biotech sector slipped all week before some green into Friday’s close. These dips are beginning to feel like the norm, though with every fresh … Continue Reading
Read now
Pacira Crumbles with Earnings, Removal of Sales Guidance
Insights - Shares of Pacira Pharmaceuticals (PCRX) took it on the chin at Thursday’s open as the company completely removed sales guidance for its only marketed product, Exparel. … Continue Reading
Read nowWhat a Friday!
Recap - Perhaps of most interest this week to long-time PropThink readers, Innate Pharma (IPH.PA)(IPHYF) took on AstraZeneca (AZN) as partner for the anti-NKG2A antibody IPH2201 on Friday morning, … Continue Reading
Read nowHealthcare Investors are Getting Ready for Back-to-Back Oncology Conferences
Recap - The first big news ahead of the American Association for Cancer Research’s (AACR) annual conference hit on Friday morning when Bristol-Myers Squibb (BMY) reported that … Continue Reading
Read now